These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37535948)

  • 1. Anti-inflammatory (Colchicine) Treatment for Secondary Prevention in Coronary Artery Disease: A Milestone has Been Met.
    Moroni F; Abbate A
    J Cardiovasc Pharmacol; 2023 Oct; 82(4):237-240. PubMed ID: 37535948
    [No Abstract]   [Full Text] [Related]  

  • 2. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease.
    Nidorf SM; Layland J; Robinson PC; Patel S; Psaltis PJ; Thompson PL
    Med J Aust; 2022 May; 216(8):385-387. PubMed ID: 35393699
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
    Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J
    Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of colchicine on patients with acute and chronic coronary artery disease.
    Madanchi M; Young M; Tersalvi G; Maria Cioffi G; Attinger-Toller A; Cuculi F; Kurmann R; Bossard M
    Eur J Intern Med; 2024 Jul; 125():1-9. PubMed ID: 38238134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.
    Nelson K; Fuster V; Ridker PM
    J Am Coll Cardiol; 2023 Aug; 82(7):648-660. PubMed ID: 37558377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Katsanos AH; Palaiodimou L; Price C; Giannopoulos S; Lemmens R; Kosmidou M; Georgakis MK; Weimar C; Kelly PJ; Tsivgoulis G
    Eur J Neurol; 2020 Jun; 27(6):1035-1038. PubMed ID: 32134555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    Abbasi J
    JAMA; 2020 Apr; 323(13):1233-1234. PubMed ID: 32186687
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-inflammatory strategies for atherosclerotic artery disease.
    Agnello F; Capodanno D
    Expert Opin Drug Saf; 2022 May; 21(5):661-672. PubMed ID: 35094611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Goh CXY; Tan YK; Tan CH; Leow AST; Ho JSY; Tan NHW; Goh S; Ho AFW; Sharma VK; Chan BPL; Yeo LLL; Tan BYQ
    J Thromb Thrombolysis; 2022 Jul; 54(1):183-190. PubMed ID: 35538274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine Leads the Charge in Post-percutaneous Coronary Intervention Anti-inflammatory Defense.
    Martinez Naya N; Toldo S; Abbate A
    J Cardiovasc Pharmacol; 2024 Mar; 83(3):231-233. PubMed ID: 38064587
    [No Abstract]   [Full Text] [Related]  

  • 16. Colchicine in coronary artery disease.
    Katira A; Katira R
    Postgrad Med J; 2022 Sep; 98(1163):718-721. PubMed ID: 33782205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    Nidorf SM; Fiolet ATL; Eikelboom JW; Schut A; Opstal TSJ; Bax WA; Budgeon CA; Tijssen JGP; Mosterd A; Cornel JH; Thompson PL;
    Am Heart J; 2019 Dec; 218():46-56. PubMed ID: 31706144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Role for Colchicine in Acute Coronary Syndromes?
    Nidorf SM; Verma S
    J Am Heart Assoc; 2015 Aug; 4(8):e002372. PubMed ID: 26304942
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Colchicine for Heart Disease.
    Bouabdallaoui N; Tardif JC
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():121-129. PubMed ID: 34587458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.